As of May 22
| +0.01 / +0.11%|
The 7 analysts offering 12-month price forecasts for Novavax Inc have a median target of 10.50, with a high estimate of 14.00 and a low estimate of 10.00. The median estimate represents a +18.38% increase from the last price of 8.87.
The current consensus among 7 polled investment analysts is to Buy stock in Novavax Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.